Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
1
Critical Role for Aberrant CpG Island Methylation in the ...
2001-09-01

... Role for Aberrant CpG Island Methylation in the Evolution and Progression of Breast Cancer: Characterization of Known Genes and Identification of ...

DTIC Science & Technology

2
Critical Role for Aberrant CpG Island Methylation in the ...
2000-09-01

... Role for Aberrant CpG Island Methylation in the Evolution and Progression of Breast Cancer: Characterization of Known Genes and Identification of ...

DTIC Science & Technology

3
Aberrantly Methylated Genes as Markers of Breast Malignancy.
2005-01-01

The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoi...

National Technical Information Service (NTIS)

4
Prediction of Breast Cancer Risk by Aberrant Methylation in ...
2002-07-01

... have identified five genes namely APC, Cyclin D2, RARbeta, RASSFlA and TMSl, that are frequently methylated in tumors. Methylation analysis of ...

DTIC Science & Technology

5
Aberrant Promoter Methylation in Serium DNA as a Biomarker ...
2005-05-01

... PROSTATE CANCER, UNITED STATES, GENES, RETINOIC ACIDS, CANCER SCREENING, SULFITES, STATISTICAL ANALYSIS, MORTALITY ...

DTIC Science & Technology

6
Aberrant Promoter Methylation in Serium DNA as a Biomarker ...
2005-05-01

... The main objective of this study is to develop a serum-based test for prostate cancer using DNA methylation of one or more candidate genes to ...

DTIC Science & Technology

7
Role of TMS1 Silencing in the Resistance of Breast Cancer Cells to Apoptosis.
2004-01-01

Aberrant DNA methylation of promoter region CpG islands is associated with gene silencing and serves as an alternative to mutations in the inactivation of tumor suppressor genes in human cancers. Our lab has identified novel gene, TMS1, that is aberrantly...

National Technical Information Service (NTIS)

8
Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts.
2010-09-22

This study evaluates the incidence and prognostic impact of aberrant methylation of 25 tumor suppressor genes in 40 patients with RARS, a MDS subtype, by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) assay. Methylation of at least one gene ...

PubMed

9
DNA methylation in endometrial cancer.
2010-08-16

Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant epigenetic change is ...

PubMed

10
DNA Methylation in Endometrial Cancer
2010-08-16

Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant epigenetic change is ...

PubMed Central

11
Role of TMS1 Silencing in the Resistance of Breast Cancer Cells to Apoptosis.
2006-01-01

Aberrant DNA methylation of promoter region CpG islands is associated with gene silencing and serves as an alternative to mutations in the inactivation of tumor suppressor genes in human cancers. We identified a gene TMS1 (for Target of Methylation-mediat...

National Technical Information Service (NTIS)

12
Critical Role for Aberrant CpG Island Methylation in the Evolution and Progression of Breast Cancer: Characterization of Known Genes and Identification of Novel Genes.
2001-01-01

CpG island methylation is an epigenetic modification of DNA associated with the silencing of gene transcription. The hypothesis of this proposal is that breast cancers develop along different pathways, some involving aberrant CpG island methylation for ge...

National Technical Information Service (NTIS)

13
Critical Role for Aberrant CpG Island Methylation in the Evolution and Progression of Breast Cancer: Characterization of Known Genes and Identification of Novel Genes.
2000-01-01

CpG island methylation is an epigenetic modification of DNA associated with the silencing of gene transcription. The hypothesis of this proposal is that breast cancers develop along different pathways, some involving aberrant CpG island methylation for ge...

National Technical Information Service (NTIS)

14
ABERRANT PROMOTER METHYLATION OF MULTIPLE GENES IN SPUTUM FROM INDIVIDUALS EXPOSED TO SMOKY COAL EMISSIONS

Aberrant methylation in the promoter region of cancer-related genes leads to gene transcriptional inactivation and plays an integral role in lung tumorigenesis. Recent studies demonstrated that promoter methylation was detected not only in lung tumors from patients with lung canc...

EPA Science Inventory

15
Development of an Assay for Prostate Cancer Based on Methylation Status of Glutathione S-Transferase (p).
2001-01-01

Glutathiaone-s-transferase (GST)-Pi gene is frequently methylated in prostate cancer and recent evidence has linked aberrant expression of this gene with the development of prostatic adenocarcinomas (PACs). The main purpose of this study is to evaluate GS...

National Technical Information Service (NTIS)

16
Systematic Identification of Genes and Signal ... - HRR - Task

In Vivo Induction of Chromosome Instability and Aberrant Patterns of DNA Methylation in Hemapoietic Stem/Progenitor Cells by Heavy Ions ...

NASA Website

17
Elucidation of the Molecular Mechanisms for Aberrant ...
2005-06-01

... CpG island methylation status and mutation analysis of the RB 1 gene essential ... B samples from cervical cancer (6 of 12) and liver cancer (1 of 2) S ...

DTIC Science & Technology

18
Elucidation of the Molecular Mechanisms for Aberrant ...
2005-06-01

... association between SNCG protein expression in primary ... sequencing and methylation-specific PCR assays, we ... CpG island of SNCG gene in every ...

DTIC Science & Technology

19
Elucidation of the Molecular Mechanisms for Aberrant ...
2003-06-01

... of a CpG island located in the exon 1 of BCSGl gene in a panel of breast tumor-derived cell lines to determine whether DNA methylation plays a ...

DTIC Science & Technology

20
Aberrant methylation of multiple genes in gastric carcinomas.
2007-07-01

In this study, we examined aberrant methylation of the E-cadherin, estrogen receptor, RB1 , p16, p15, p14, and MGMT genes by the methylation-specific polymerase chain reaction method in 101 gastric carcinomas. Hypermethylation was detected in E-cadherin, estrogen receptor, RB1, p16, p14, p15, and MGMT at the rates ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
21
Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model.
2010-01-01

Mouse models of intestinal tumors have advanced our understanding of the role of gene mutations in colorectal malignancy. However, the utility of these systems for studying the role of epigenetic alterations in intestinal neoplasms remains to be defined. Consequently, we assessed the role of aberrant DNA methylation in the azoxymethane ...

PubMed

22
Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model
2010-01-01

Mouse models of intestinal tumors have advanced our understanding of the role of gene mutations in colorectal malignancy. However, the utility of these systems for studying the role of epigenetic alterations in intestinal neoplasms remains to be defined. Consequently, we assessed the role of aberrant DNA methylation in the azoxymethane ...

PubMed Central

23
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.
2011-02-28

Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this mechanism to contribute to tumor development depends on whether the genes affected are repressed because of their methylation. Many aberrantly methylated genes play important roles ...

PubMed

24
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer
2011-03-15

Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this mechanism to contribute to tumor development depends on whether the genes affected are repressed because of their methylation. Many aberrantly methylated genes play important roles ...

PubMed Central

25
[CANCER RESEARCH 64, 2000�2006, March 15, 2004] Hypermethylation of the 5 CpG Island of the FHIT Gene Is Associated with

leukemia in Northern California. We measured DNA methylation in the promoter region of the FHIT gene in 190 of the FHIT gene, and methylation in this region correlates with loss of FHIT expression. To test whether aberrant methylation of the FHIT gene ...

E-print Network

26
Epigenetic Changes in DNA Methylation in Breast Cancer.
2001-01-01

It is now clear that aberrant DNA methylation observed in cancer cells is not restricted to a few CpG islands, but affects multiple loci. When this epigenetic event occurs at the 5-end of the regulatory region of genes, it is frequently associated with tr...

National Technical Information Service (NTIS)

27
[Diagnostics for epigenetic pathology in hereditary and oncologic diseases].

The review considers the epigenetic defects and their diagnostics in several hereditary disorders and tumors. Aberrant methylation of the promoter or regulatory region of a gene results in its functional inactivation, which is phenotypically similar to structural deletion. Screening tests were developed for Prader-Willi, Angelman, ...

PubMed

28
Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer1
2004-07-01

AbstractThe maspin gene functions as a tumor suppressor in human breasts, and its expression is frequently lost during breast cancer progression. In vitro models of human breast cancer indicate that the loss of maspin expression is closely linked to aberrant methylation of the maspin promoter. We conducted a study on 30 archival ductal ...

PubMed Central

29
Methylation destiny: Moira takes account of histones and RNA polymerase II.
2010-02-27

Aberrant DNA methylation is deeply involved in various human disorders. Contrary to our initial expectation, aberrant methylation is now known to possess several unique characteristics different from mutations, including target gene specificity. Specific cancers have ...

PubMed

30
Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation.
2011-08-01

Aims The purpose of this study was to compare the DNA-methylation signature in classic chronic Philadelphia negative myeloproliferative neoplasms (MPN), polycythaemia vera (PV) and essential thrombocythaemia (ET), in order to obtain a global insight into DNA-methylation changes associated with these malignancies. Methods Thirty-five MPN samples from 11 ET ...

PubMed

31
Consistent DNA hypermethylation patterns in laryngeal papillomas.
2010-05-01

INTRODUCTION: This study examined the contribution of promoter hypermethylation to the pathogenesis of respiratory papillomatosis (RP), including recurrences (RRP) and progression to squamous cell carcinoma (SSC). MATERIALS AND METHODS: A retrospective cohort of 25 laryngeal papilloma cases included 21 RRP, two of which progressed to SCC. Aberrant ...

PubMed

32
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia.
2005-07-21

Methylation profile was analyzed in 10 childhood acute lymphoblastic leukemia (ALL) and nine adult ALL cases. Four genes (p15, p16, RARbeta, FHIT) had methylation in both diseases, four genes (p14, Rb, MLH1, DAPK) showed no methylation in both diseases, and the two genes ...

PubMed

33
Aberrant DNA methylation in malignant melanoma
2010-08-01

Malignant Melanoma remains one of the most deadly human cancers with no effective cures for metastatic disease. The poor efficacy of current therapy in advanced melanoma highlights the need for better understanding of molecular mechanisms contributing to the disease. Recent work has shown that epigenetic changes, including aberrant DNA methylation, lead to ...

PubMed Central

34
Body-methylated genes in Arabidopsis thaliana are functionally important and evolve slowly.
2011-08-01

DNA methylation of coding regions, known as gene body methylation, is conserved across eukaryotic lineages. The function of body methylation is not known, but it may either prevent aberrant expression from intragenic promoters or enhance the accuracy of splicing. Given these putative functions, ...

PubMed

35
Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer.
2010-09-22

Head and neck cancer (HNC) is a common cancer, and its prognosis has not changed during the last decades. Detection of the disease at an early stage is crucial for successful treatment, as early diagnosis can significantly increase the survival rate. Methylation of tumor suppressor genes is an early event in cancer responsible for incorrect ...

PubMed

36
Nested methylation-specific polymerase chain reaction cancer detection method
2007-05-08

A molecular marker-based method for monitoring and detecting cancer in humans. Aberrant methylation of gene promoters is a marker for cancer risk in humans. A two-stage, or "nested" polymerase chain reaction method is disclosed for detecting methylated DNA sequences at sufficiently high levels of sensitivity to ...

DOE Information Bridge

37
The MIRA method for DNA methylation analysis
2009-01-01

DNA methylation patterns are often altered in human cancer and aberrant methylation is considered a hallmark of malignant transformation. Several methods have been developed for the characterization of gene-specific and genome-wide DNA methylation patterns. In this chapter, we describe the ...

PubMed Central

38
Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer
2011-04-01

Human cancer cells frequently have regions of their DNA hypermethylated, which results in transcriptional silencing of affected genes and promotion of tumor formation. However, it is still unknown whether cancer-associated aberrant DNA methylation is targeted to specific genomic regions, whether this methylation ...

PubMed Central

39
Prediction of Breast Cancer Risk by Aberrant Methylation in ...
2005-07-01

... Accession Number : ADA438496. Title : Prediction of Breast Cancer Risk by Aberrant Methylation in Mammary Duct Lavage. ...

DTIC Science & Technology

40
[CANCERRESEARCH57. 2619�"2622,July 1, 19971 Advances in Brief

. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene, FMR1, submitted/pI6IMTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers demonstrate that the methylation assay can be performed on 2 ug ofDNA ...

E-print Network

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
41
Epigenetic aberration of the human REELIN gene in psychiatric disorders.
2007-02-20

Epigenetic genome modifications such as DNA methylation appear to be involved in various diseases. Here, we suggest that the levels of DNA methylation at the BssHII methylation-sensitive restriction enzyme sites in the human REELIN (RELN) gene in the forebrain vary among individuals. Interestingly, although a ...

PubMed

42
Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer.
2007-01-01

The relationship of aberrant DNA hypermethylation of cell cycle checkpoint genes with the sensitivity of cancer cells to anticancer drugs is a question of current interest. In this study, we investigated the relationship between aberrant hypermethylation of the CHFR (checkpoint with forkhead-associated and ring finger) mitotic ...

PubMed

43
Dissecting DNA hypermethylation in cancer.
2010-12-10

There is compelling evidence to support the importance of DNA methylation alterations in cancer development. Both losses and gains of DNA methylation are observed, thought to contribute pathophysiologically by inactivating tumor suppressor genes, inducing chromosomal instability and ectopically activating gene ...

PubMed

44
DNA methylation and cancer pathways in gastrointestinal tumors.
2008-12-01

Cancer is fundamentally a genetic and epigenetic disease that requires the accumulation of genomic alterations that inactivate tumor suppressors and activate proto-oncogenes. In addition to genetic mutation or allelic loss, epigenetic gene silencing associated with DNA methylation is now recognized as an alternative mechanism by which tumor suppressor ...

PubMed

45
Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer.
2010-03-19

Runx3 and CHFR genes were defined as tumor suppressor genes in gastric cancer (GC) recently. This paper was to investigate the roles of methylation and expression status of Runx3 and CHFR genes in GC patients. Methylation-specific polymerase chain reaction (MSP) and bisulfite DNA sequencing ...

PubMed

46
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors
2009-01-01

The global rise in lung cancer burden, together with its poor survival and resistance to classical chemotherapy underscores the need for identification of critical molecular events involved in lung carcinogenesis. Here, we have applied quantitative profiling of DNA methylation states in a panel of five cancer-associated genes (CDH1, CDKN2A, GSTP1, MTHFR ...

PubMed Central

47
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
2009-02-05

Myelodysplastic syndromes (MDSs) are clonal hematologic disorders that frequently represent an intermediate disease stage before progression to acute myeloid leukemia (AML). As such, study of MDS/AML can provide insight into the mechanisms of neoplastic evolution. In 184 patients with MDS and AML, DNA methylation microarray and high-density single nucleotide polymorphism array ...

PubMed Central

48
Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma
2011-06-05

BackgroundN-methyl-D-aspartate receptors (NMDAR) act as tumor suppressors of digestive malignancies. The expression and genetic methylation patterns of NMDAR2B in non-small cell lung cancer (NSCLC) are unknown.MethodsThe relationship between gene methylation and expression of NMDAR2B was analyzed in NSCLC cell ...

PubMed Central

49
Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme
2010-01-14

Disruption of apoptosis is considered as an important factor aiding tumorigenesis, and aberrant DNA methylation of apoptosis-associated genes could be an important and significant mechanism through which tumor cells avoid apoptosis. However, little is known about (1) the impact of methylation status of ...

PubMed Central

50
Transcriptional Repression as a Mechanism of BRCA-1 Inactivation.
2000-01-01

The basic hypothesis of this project is that aberrant cytosine methylation of the BRCA-1 CpG island promoter is a mechanism of BRCA-1 gene inactivation in sporadic human breast cancer. To test this hypothesis, archived frozen human breast cancer specimens...

National Technical Information Service (NTIS)

51
Epigenetic Characterization of Ovarian Cancer.
2008-01-01

The overall objective of this research was to identify genes that are aberrantly methylated in epithelial ovarian cancer. Our approach was to treat or mock treat primary normal or tumor cultured cells with drugs that inhibit DNA methyltransferase activity...

National Technical Information Service (NTIS)

52
Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR
2006-07-05

Methylation of CpG islands is associated with transcriptional repression and, in cancer, leads to the abnormal silencing of tumor suppressor genes. We have developed a novel technique for detecting CpG-methylated DNA termed methyl-binding (MB)-PCR. This technique utilizes a recombinant protein with high affinity ...

PubMed Central

53
Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target.
2011-06-09

Endometriosis, a common, benign, estrogen-dependent disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue that is found primarily in the peritoneum, ovaries and rectovaginal septum. Recently, endometriosis has been alternatively described as an immune disease, a genetic disease and a disease caused by exposure to environmental factors, ...

PubMed

54
Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome.
2010-12-09

In Down's syndrome there is evidence that increased gene expression coding for specific cystathionine beta-synthase translates directly into biochemical aberrations, which result in a biochemical and metabolic imbalance of the methyl status. This event is destined to impact mitochondrial function since methylation ...

PubMed

55
Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
2011-07-14

Epigenetic events have emerged as key mechanisms in the regulation of critical biological processes and in the development of a wide variety of human malignancies, including gastric cancer (GC), however precise gene targets of aberrant DNA methylation in GC remain largely unknown. Here, we have combined pyrosequencing-based ...

PubMed

56
Array-based DNA methylation profiling in acute myeloid leukaemia.
2011-07-26

Methylation in the promoter region of many genes is involved in regulating gene expression patterns. Using the Illumina GoldenGate(�) methylation assay, we examined the methylation status of 1505 CpG-sites from 807 genes in 32 samples from patients with acute myeloid ...

PubMed

57
Expression of IGFBP7 in acute leukemia is regulated by DNA methylation.
2010-10-29

The important role of insulin-like growth factor binding protein 7 (IGFBP7) as a tumor suppressor in solid tumors has been revealed in several studies. Interestingly, in a recent study IGFBP7 was also shown to be aberrantly expressed in acute leukemia. Moreover, in acute T-lymphoblastic leukemia (T-ALL), high IGFBP7 expression predicts primary therapy resistance. In order to ...

PubMed

58
Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells
2009-12-01

Aberrant DNA methylation participates in carcinogenesis and is a molecular hallmark of a tumor cell. Tumor cells generally exhibit a redistribution of DNA methylation resulting in global hypomethylation with regional hypermethylation; however, the speed in which these changes emerge has not been fully elucidated and may depend on the ...

Energy Citations Database

59
Arsenicals Produce Stable Progressive Changes in DNA Methylation Patterns that are Linked to Malignant Transformation of Immortalized Urothelial Cells
2009-08-28

Aberrant DNA methylation participates in carcinogenesis and is a molecular hallmark of a tumor cell. Tumor cells generally exhibit a redistribution of DNA methylation resulting in global hypomethylation with regional hypermethylation; however, the speed in which these changes emerge has not been fully elucidated and may depend on the ...

PubMed Central

60
Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.

Aberrant methylation of the promoter CpG island of human genes is an alternative gene inactivation mechanism that contributes to the carcinogenesis of human tumours. We have determined the methylation status of the CpG island of 11 tumour-related genes (RB1, p14ARF, ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
61
Surfactant protein DNA methylation: A new entrant in the field of lung cancer diagnostics? (Review)
2009-01-01

Lung cancer is a major cause of cancer-related mortality in both men and women. A 5-year survival of lung cancer patients is only 15% with a negative correlation between progressively advanced lung cancer stage and a 5-year survival period. The only chance for cure is surgical resection if done at the early stage of the disease. Therefore, an early diagnosis and a better prediction of prognosis ...

PubMed Central

62
Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
2002-02-01

The aberrant methylation of cytosine residues in the promoter region of growth regulatory genes is now widely recognized as an additional mechanism for gene inactivation in cancer cells. In this study we analyzed the methylation status of four growth regulatory genes (p16, ...

PubMed Central

63
Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia
2011-07-08

The epigenetic impact of DNA methylation in chronic myelogenous leukemia (CML) is not completely understood. To elucidate its role we analyzed 120 patients with CML for methylation of promoter-associated CpG islands of 10 genes. Five genes were identified by DNA methylation screening in the ...

PubMed Central

64
Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
2004-07-01

Methylation profile was analyzed in nine cases of relapsed childhood acute lymphoblastic leukemia (ALL) for p14, p15, p16, Rb, MGMT, APC, hMLH1, RARbeta, RIZ, DAPK, and FHIT genes by using methylation specific polymerase chain reaction (MSP) analysis. Frequency of methylation in each gene was: ...

PubMed

65
Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma
2008-04-29

Many genes undergo aberrant methylation in human cancers, and microarray platforms enable more comprehensive profiling of aberrant DNA methylation patterns.Results1,010 of 87,922 probes on the 88 K promoter array (606 genes) had a higher signal (log2 ...

PubMed Central

66
De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia.
1997-11-01

De novo methylation of the 5'CpG island has been recently reported as an alternative mechanism of inactivation for the tumour suppressor genes CDKN2A and CDKN2B. We examined CDKN2A methylation status at diagnosis in 42 B-cell chronic lymphocytic leukaemia (CLL) patients, in 19 cases the CDKN2B methylation status ...

PubMed

67
Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma
2008-08-28

AIM: To investigate the aberrant methylation of CHFR promoter in human gastric cancer (GC) and its impact on the expression of CHFR mRNA and protein, as well as its correlation with clinical and histological features of human GC.METHODS: Methylation-specific polymerase chain reaction (MSPCR) was used to detect the ...

PubMed Central

68
Aberrant methylation as a main mechanism of TSGs silencing in PTC.
2011-01-01

In the present study the role of tumour suppressor genes (TSGs) hypermethylation and genetic instability of LOH/MSI type in thyroid tumorigenesis was assessed. Expression, methylation status and presence of LOH/MSI were analyzed for 8 TSGs selected from imprinted (IR) and non-imprinted (NIR) chromosomal regions in papillary thyroid carcinomas (PTCs) and ...

PubMed

69
Quantitative Methylation-specific PCR for the Detection of Aberrant DNA Methylation in Liquid-based Pap Tests
2008-02-25

BACKGROUNDAberrant promoter methylation of selective tumor suppressor genes has been detected in squamous intraepithelial lesions (SIL) and invasive cervical cancer. Identification of methylation profiles of genes that can distinguish high-grade SIL (HSIL) from low-grade SIL (LSIL), and cytologically negative for ...

PubMed Central

70
Aberrant DNA methylation at imprinted genes in testicular sperm retrieved from men with obstructive azoospermia and undergoing vasectomy reversal.
2011-03-09

Male factor infertility has been associated with abnormal DNA methylation at imprinted genes. Little information is available on the status of imprinting in the sperm of men with azoospermia, including the association between aberrant imprinting and obstructive azoospermia (OA) or non-OA (NOA). Analysis of DNA ...

PubMed

71
Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
2009-11-01

Improvements in epigenetics have resulted in identification of a number of genes with aberrant hypermethylation associated with systematic occurrence of cancer. It is now evident that aberrant hypermethylation inactivates cancer-related genes including those associated with cell cycle control, apoptosis, and DNA ...

PubMed

72
Frequent aberrant methylation of p16{sup INK4a} in primary rat lung tumors
1997-03-01

The p16{sup INK4a} (p16) tumor suppressor gene is frequently inactivated by homozygous deletion or methylation of the 5{prime} CpG island in cell lines derived from human non-small-cell lung cancers. However, the frequency of dysfunction in primary tumors appears to be significantly lower than that in cell lines. This discordance could result from the ...

Energy Citations Database

73
Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas.
2011-05-12

Aberrant DNA methylation is deeply involved in the development and progression of human breast cancers, but its inducers and molecular mechanisms are still unclear. To reveal such inducers and clarify the molecular mechanisms, animal models are indispensable. Here, to identify genes silenced by promoter DNA ...

PubMed

74
Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls
2007-02-26

IntroductionFemale germline BRCA gene mutation carriers are at increased risk for developing breast cancer. The purpose of our study was to establish whether healthy BRCA mutation carriers demonstrate an increased frequency of aberrant gene promoter hypermethylation in ductal lavage (DL) fluid, compared with predictive genetic test ...

PubMed Central

75
Aberrant promoter methylation of multiple genes in sputum from individuals exposed to smoky coal emissions

SummaryAberrant methylation in the promoter region of cancer-related genes leads to gene transcriptional inactivation and plays an integral role in lung tumorigenesis. Recent studies demonstrated that promoter methylation was detected not only in lung tumors from patients with lung cancer but ...

PubMed Central

76
Epigenetic regulation of Wnt signaling pathway in urological cancer.
2010-05-10

Constitutive activation of the Wnt signaling pathway is a common feature of solid tumors and contributes to uncontrolled cell-growth and impaired differentiation. We hypothesized that gene silencing mediated through aberrant promoter methylation of upstream Wnt antagonist genes might result in beta-catenin ...

PubMed

77
The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.
2004-12-16

Several epidemiological studies on ataxia-telangiectasia families indicate that obligate ATM heterozygotes display an elevated risk for developing breast cancer. However, a molecular basis for a potential link between diminished ATM function and sporadic breast malignancy remains elusive. Here, we show that 78% (18 out of a panel of 23) of surgically removed breast tumors (stage II or greater) ...

PubMed

78
Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
2007-10-01

A relationship between inactivation of mitotic checkpoint genes and sensitivity of cancer cells to anticancer agents has been reported. We investigated the effect of epigenetic inactivation by aberrant hypermethylation of the mitotic checkpoint gene CHFR (checkpoint with forkhead and ring finger) on the sensitivity of cervical cancer ...

PubMed

79
NCI Funded Research Portfolio - Z01 BC 010669 Detail

We recently discovered that aberrant gene methylation occurs in the stroma and endothelium adjacent to tumor epithelium in prostate cancer patients. This suggests that epigenetic changes such as gene hypermethylation may play a role in the tumor microenvironment. These findings have implications for prostate cancer ...

Cancer.gov

80
Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.
2006-01-01

A genome-wide screening study for identification of hypermethylated genes in invasive cervical cancer (ICC) was carried out to augment our previously discovered panel of three genes found to be useful for detection of ICC and its precursor neoplasia. Putatively hypermethylated and silenced genes were reactivated in four ICC cell lines ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
81
Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.
2010-09-20

DNA methylation patterns are frequently dysregulated in cancer, although little is known of the mechanisms through which specific gene sets become aberrantly methylated. The ecotropic viral integration site 1 (EVI1) locus encodes a DNA binding zinc-finger transcription factor that is aberrantly ...

PubMed

82
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis
2010-01-01

SummaryHuman cancer genomes are characterized by widespread aberrations in DNA methylation patterns including DNA hypomethylation of mostly repetitive sequences and hypermethylation of numerous CpG islands. The analysis of DNA methylation patterns in cancer has progressed from single gene studies examining ...

PubMed Central

83
Does Aberrant DNA Methylation Occur in Human Uterine Leiomyomas? An Attempt of Genome-Wide Screening by MS-RDA.
2011-09-20

Objective: Uterine leiomyoma are very common benign tumors in women of reproductive age. However, the molecular mechanisms of cause and development of these tumors are poorly understood. This study attempts to examine whether or not aberrant DNA methylation occurred in these tumors. Methods: We carried out a genome-wide screen for ...

PubMed

84
Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation Specific PCR
2010-06-30

PurposeAberrant promoter hypermethylation of tumor suppressor genes is a promising marker for lung cancer detection. We investigated the likelihood of detecting aberrant DNA methylation of tumor suppressor genes, in plasma samples of patients with abnormalities of the lung detected upon ...

PubMed Central

85
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype
2008-10-07

Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter occurs in about 40% of breast tumours and has been correlated with reduced APC protein levels. To what extent epigenetic alterations of the APC gene may differ according to specific breast cancer phenotypes, remains to be elucidated. Our aim ...

PubMed Central

86
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.
2009-05-12

We have used a gene expression array-based strategy to identify the methylation of tissue factor pathway inhibitor 2 (TFPI2), a potential tumor suppressor gene, as a frequent event in human colorectal cancers (CRC). TFPI2 belongs to the recently described group of embryonic cell Polycomb group (PcG)-marked genes ...

PubMed

87
Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
2009-05-12

We have used a gene expression array�based strategy to identify the methylation of tissue factor pathway inhibitor 2 (TFPI2), a potential tumor suppressor gene, as a frequent event in human colorectal cancers (CRC). TFPI2 belongs to the recently described group of embryonic cell Polycomb group (PcG)�marked ...

PubMed Central

88
Clinical Significance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma
2009-07-29

Aberrant hypermethylation of gene promoter regions is one of the mechanisms for inactivation of tumour suppressor genes in many human cancers including breast carcinoma. In the current study, we aimed to assess by MSP, the methylation pattern of two cancer-related genes involved in DNA repair: ...

PubMed Central

89
Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
2009-11-01

Recent studies have shown that promoter hypermethylation of tumor suppressor genes is an important factor in carcinogenesis of several human organs. The purpose of this study was to examine the methylation status of CHFR, a novel cell cycle regulatory gene, in both primary oral cancer tumors and the adjacent normal mucosa, and to ...

PubMed

90
Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
2002-03-27

A higher prevalence of epigenetic inactivation of tumor suppressor genes has been reported in cancer cell line populations compared to primary cancer populations. Cancer-related genes are commonly methylated in cancer cell lines but it is not known the extent to which tumor suppressor genes may be artificially ...

PubMed

91
TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma.
2009-10-15

Multiple myeloma (MM) is an incurable hematological malignancy. Different studies demonstrated the occurrence of genetic and epigenetic alterations in MM. The aberrant methylation is one of the most frequent epigenetic alterations in human genome. This study evaluated the aberrant methylation status of 20 ...

PubMed

92
Reversible histone methylation regulates brain gene expression and behavior.
2010-09-15

Epigenetic chromatin remodeling, including reversible histone methylation, regulates gene transcription in brain development and synaptic plasticity. Aberrant chromatin modifications due to mutant chromatin enzymes or chemical exposures have been associated with neurological or psychiatric disorders such as mental retardation, ...

PubMed

93
Reversible histone methylation regulates brain gene expression and behavior
2010-09-15

Epigenetic chromatin remodeling, including reversible histone methylation, regulates gene transcription in brain development and synaptic plasticity. Aberrant chromatin modifications due to mutant chromatin enzymes or chemical exposures have been associated with neurological or psychiatric disorders such as mental retardation, ...

PubMed Central

94
Aberrant CpG island methylation of multiple genes in ependymal tumors.

Aberrant methylation of promoter CpG islands in human genes represents an alternative mechanism for genetic inactivation, and contributes to the development of human tumors. Nevertheless, thus far, few reports have analyzed methylation in ependymomas. We determined the frequency of aberrant CpG ...

PubMed

95
Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation
2009-10-01

Alcohol exposure during development can cause variable neurofacial deficit and growth retardation known as fetal alcohol spectrum disorders (FASD). The mechanism underlying FASD is not fully understood. However, alcohol, which is known to affect methyl donor metabolism, may induce aberrant epigenetic changes contributing to FASD. Using a tightly controlled ...

PubMed Central

96
Minireview: Epigenetic Changes in Ovarian Cancer
2009-09-02

Epigenetic aberrations, including DNA methylation, histone modifications, and micro-RNA dysregulation, are now well established in the development and progression of ovarian cancer, and their gradual accumulation is associated with advancing disease stage and grade. Epigenetic aberrations are relatively stable, associated with distinct ...

PubMed Central

97
Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer
2008-10-01

PurposeThe aims of our study were to elucidate the role of methylation of a large panel of genes during multistage pathogenesis of bladder cancer and to correlate our findings with patient age and other clinicopathologic features.Experimental DesignWe studied the methylation status of 21 genes by quantitative ...

PubMed Central

98
Frequent aberrant methylation of p16INK4a in primary rat lung tumors.
1997-03-01

The p16INK4a (p16) tumor suppressor gene is frequently inactivated by homozygous deletion or methylation of the 5' CpG island in cell lines derived from human non-small-cell lung cancers. However, the frequency of dysfunction in primary tumors appears to be significantly lower than that in cell lines. This discordance could result from the occurrence or ...

PubMed

99
Frequent aberrant methylation of p16INK4a in primary rat lung tumors.
1997-03-01

The p16INK4a (p16) tumor suppressor gene is frequently inactivated by homozygous deletion or methylation of the 5' CpG island in cell lines derived from human non-small-cell lung cancers. However, the frequency of dysfunction in primary tumors appears to be significantly lower than that in cell lines. This discordance could result from the occurrence or ...

PubMed Central

100
Prediction of epigenetically regulated genes in breast cancer cell lines
2010-05-04

Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-throughput microarrays to measure CpG island ...

Energy Citations Database

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
101
[Epigenetic inactivation of the RB1 gene as a factor of genomic instability: a possible contribution to etiology of chromosomal mosaicism during human embryo development].
2008-11-01

The methylation status of the cell cycle control gene RB1 has been studied in placental tissues of spontaneous abortions of the first trimester of pregnancy with mosaic variants of numerical chromosomal abnormalities verified by a molecular genetic examination. Aberrant methylation of the gene ...

PubMed

102
Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
2011-08-25

The aberrant methylation of promoter CpG islands is known to be a major inactivation mechanism of tumor-related genes, which plays a crucial role in the progression of silencing in human cancers including hepatocellular carcinoma (HCC). Thus, we sought to examine the promoter methylation status of five important ...

PubMed

103
Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers
2010-04-13

Heritable germline epimutations in MSH2 have been reported in a small number of Lynch Syndrome families which lacked germline mutations in the MSH2 gene. It is not known whether somatic MSH2 methylation occurs in MSH2 mutation-positive Lynch Syndrome subjects or sporadic colorectal cancers (CRCs). Therefore, we determined the ...

PubMed Central

104
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing
2010-02-25

BackgroundCancer cells undergo massive alterations to their DNA methylation patterns that result in aberrant gene expression and malignant phenotypes. However, the mechanisms that underlie methylome changes are not well understood nor is the genomic distribution of DNA methylation changes well ...

PubMed Central

105
DNA methylation profile during multistage progression of pulmonary adenocarcinomas.
2011-04-15

Multiple genetic and epigenetic alterations are known to be involved in the carcinogenesis of peripheral pulmonary adenocarcinoma (ADC). However, epigenetic abnormalities have not been extensively investigated in the following multistage progression sequence: atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), to invasive ADC. To determine the potential role of promoter ...

PubMed

106
Methylation of Multiple Genes in Gastric Glands with Intestinal Metaplasia
2006-11-01

Gene silencing by methylation of promoter CpG islands is deeply involved in cancers, but its involvement in polyclonal disorders is still unclear. Here, we analyzed the presence of gene silencing in intestinal metaplasia (IM) of the stomach, a polyclonal disorder, in which multiple gastric glands aberrantly ...

PubMed Central

107
Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.
2011-05-23

Aberrant methylation of gene promoters and corresponding loss of gene expression plays a critical role in the initiation and progression of colorectal cancer. An IL-6-type cytokine receptor, leukemia inhibitory factor receptor (LIFR), is a component of cell-surface receptor complexes for multifunctional cytokines ...

PubMed

108
Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
2011-06-10

BackgroundLong-term gene silencing throughout cell division is generally achieved by DNA methylation and other epigenetic processes. Aberrant DNA methylation is now widely recognized to be associated with cancer and other human diseases. Here we addressed the contribution of the multifunctional nuclear factor CTCF ...

PubMed Central

109
Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
2010-03-24

BackgroundWnt inhibitory factor-1(WIF-1) acts as a Wnt-antagonists and tumor suppressor, but hypermethylation of WIF-1 gene promoter and low expression activate Wnt signaling aberrantly and induce the development of various human tumors. With this work we intended to investigate the expression and promoter methylation status of WIF-1 ...

PubMed Central

110
Conservation and divergence of DNA methylation in eukaryotes: new insights from single base-resolution DNA methylomes.
2011-02-01

DNA methylation is one of the most important heritable epigenetic modifications of the genome and is involved in the regulation of many cellular processes. Aberrant DNA methylation has been frequently reported to influence gene expression and subsequently cause various human diseases, including cancer. Recent rapid ...

PubMed

111
Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
2010-09-09

We performed methylation specific PCR analysis on the RIZ1 promoter in MDS and AML. Methylation was detected in 17 of 34 MDS (50%) and 22 of 72 AML (31%) (p=0.053). Methylation was detected in eleven of 17 secondary AML from MDS (65%), and eleven of 55 de novo AML (20%) (p=0.0005). Bisulfite sequence revealed ...

PubMed

112
[Aberrant methylation of tumor suppressor genes and allelic imbalance in cervical intraepitelial neoplasia].

We analysed 42 high-grade CIN or CIN3 samples, 42 nondysplasia tissues adjacent to CIN3. 35 smears from women without gynecological pathology were also evaluated. Methylation status of six genes (p16, MLH1, HIC1, MGMT, N33 and RB1) was determined using methylation-sensitive PCR. There is some insignificant level of ...

PubMed

113
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.
2011-05-17

Methylation profile was analyzed in ninety-five patients with childhood acute lymphoblastic leukemia (ALL). Methylation of both MGMT and p16 genes were associated with higher age (p=0.01 and p=0.03, respectively). Methylation of both p15 and SHP1 genes occurred more frequently in T-ALL than in ...

PubMed

114
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
2008-09-04

Human cancer cells typically harbour multiple chromosomal aberrations, nucleotide substitutions and epigenetic modifications that drive malignant transformation. The Cancer Genome Atlas (TCGA) pilot project aims to assess the value of large-scale multi-dimensional analysis of these molecular characteristics in human cancer and to provide the data rapidly to the research ...

PubMed

115
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008-09-04

Human cancer cells typically harbor multiple chromosomal aberrations, nucleotide substitutions and epigenetic modifications that drive malignant transformation. The Cancer Genome Atlas (TCGA) pilot project aims to assess the value of large-scale multidimensional analysis of these molecular characteristics in human cancer and to provide the data rapidly to the research ...

PubMed Central

116
Integrated genomic analyses of ovarian carcinoma.
2011-06-29

A catalogue of molecular aberrations that cause ovarian cancer is critical for developing and deploying therapies that will improve patients' lives. The Cancer Genome Atlas project has analysed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of ...

PubMed

117
Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
2011-04-01

DNA and histone methylation are epigenetic modifications functioning in transcriptional control and have been implicated in the deregulation of gene expression in cancer. As a first step to determine if histone methylation could be involved in testis cancer pathogenesis, we performed immunofluorescent localization of histone H3 ...

PubMed

118
Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
2011-06-27

Background and aims The majority of gastrointestinal stromal tumors (GISTs) have KIT mutations; however, epigenetic abnormalities that could conceivably potentiate the aggressiveness of GISTs are largely unidentified. Our aim was to establish epigenetic profiles associated with the malignant transformation of GISTs. Methods Methylation of four tumor suppressor ...

PubMed

119
Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de Novo DNA methyltransferase

Aberrant DNA methylation is common in carcinogenesis. The typical pattern appears to involve reduced expression of maintenance DNA methyltransferase, DNMT1, inducing genomic hypomethylation, whereas increased expression of de novo DNMT3a or 3b causes gene-specific hypermethylation. During cadmium-in...

Technology Transfer Automated Retrieval System (TEKTRAN)

120
Investigating the Epigenetic Effects of a Prototype Smoke-Derived Carcinogen in Human Cells
2010-05-12

Global loss of DNA methylation and locus/gene-specific gain of DNA methylation are two distinct hallmarks of carcinogenesis. Aberrant DNA methylation is implicated in smoking-related lung cancer. In this study, we have comprehensively investigated the modulation of DNA ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
121
Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes.
2004-06-01

The simian polyoma virus SV40 has been detected in specific human tumors including non-Hodgkin's lymphomas, although a causative role for the virus has not been convincingly demonstrated. Aberrant methylation of CpG islands in promoter regions is a frequent method of silencing tumor suppressor genes (TSGs) in cancers and may be induced ...

PubMed

122
MeInfoText: associated gene methylation and cancer information from text mining
2008-01-14

BackgroundDNA methylation is an important epigenetic modification of the genome. Abnormal DNA methylation may result in silencing of tumor suppressor genes and is common in a variety of human cancer cells. As more epigenetics research is published electronically, it is desirable to extract relevant information from biological ...

PubMed Central

123
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
2009-10-15

Increasing evidence shows aberrant hypermethylation of genes occurring in and potentially contributing to pathogenesis of myeloid malignancies. Several of these diseases, such as myelodysplastic syndromes (MDSs), are responsive to DNA methyltransferase inhibitors. To determine the extent of promoter hypermethylation in such tumors, we compared the ...

PubMed Central

124
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
2010-08-19

Mantle cell lymphoma (MCL) is a mostly incurable malignancy arising from naive B cells (NBCs) in the mantle zone of lymph nodes. We analyzed genomewide methylation in MCL patients with the HELP (HpaII tiny fragment Enrichment by Ligation�mediated PCR) assay and found significant aberrancy in promoter methylation patterns compared ...

PubMed Central

125
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
2009-06-09

DNA methylation plays a crucial role in the regulation of gene expression and chromatin organization within normal eukaryotic cells. In cancer, however, global patterns of DNA methylation are altered with global hypomethylation of repeat-rich intergenic regions and hypermethylation of a subset of CpG-dense ...

PubMed Central

126
High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance
2010-06-08

Acquired drug resistance represents a frequent obstacle which hampers efficient chemotherapy of cancers. The contribution of aberrant DNA methylation to the development of drug resistant tumor cells has gained increasing attention over the past decades. Hence, the objective of the presented study was to characterize DNA methylation ...

PubMed Central

127
Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
2006-02-01

The epigenetic changes in pituitary adenomas were identified by evaluating the methylation status of nine genes (RB1, p14(ARF), p16(INK4a), p73, TIMP-3, MGMT, DAPK, THBS1 and caspase-8) in a series of 35 tumours using methylation-specific PCR analysis plus sequencing. The series included non-functional adenomas (n=23), prolactinomas ...

PubMed

128
CpG island methylation of BNIP3 predicts resistance against S-1/CPT-11 combined therapy in colorectal cancer patients.
2010-01-01

Aberrant gene methylation is frequently observed in various cancers and plays an important role in carcinogenesis, cancer progression and drug responsiveness. The aim of this study is to identify colorectal cancer specific gene methylation determining chemosensitivity to S-1/CPT-11 therapy. The ...

PubMed

129
Epigenetic Changes in the Myelodysplastic Syndrome
2010-04-01

Epigenetic mechanisms such as DNA methylation and histone modifications drive stable, clonally propagated changes in genes expression and can therefore serve as molecular mediators of pathway dysfunction in neoplasia. MDS is characterized by frequent epigenetic abnormalities, including the hypermethylation of genes that control ...

PubMed Central

130
Methylation analysis of circadian clock gene promoters in forensic autopsy specimens.
2011-05-18

DNA methylation in gene promoter regions influences gene expression. Circadian clock genes play an important role in the formation of a biological clock and aberrant methylation of these genes contributes to several disorders. In this study, we examined ...

PubMed

131
Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers
2009-07-12

Aberrant promoter hypermethylation is one of the major mechanisms in carcinogenesis and some critical growth regulatory genes have shown commonality in methylation across solid tumors. Twenty-six genes, 14 identified through methylation in colon and breast cancers, were evaluated using primary ...

PubMed Central

132
Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.
2010-11-23

Our previous studies revealed a variety of genetic changes in lung cancers from chromate-exposed workers (chromate lung cancer). In the present study, we examined epigenetic changes in chromate lung cancers. Nested-methylation-specific PCR was employed in studying the methylation of CpG islands in the APC, MGMT, hMLH1 genes in 36 ...

PubMed

133
Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.
2010-11-23

Our previous studies revealed a variety of genetic changes in lung cancers from chromate-exposed workers (chromate lung cancer). In the present study, we examined epigenetic changes in chromate lung cancers. Nested-methylation-specific PCR was employed in studying the methylation of CpG islands in the APC, MGMT, hMLH1 genes in 36 ...

PubMed

134
Genome-wide, high-resolution DNA methylation profiling using bisulfite-mediated cytosine conversion
2008-03-01

Methylation of cytosines (mC) is essential for epigenetic gene regulation in plants and mammals. Aberrant mC patterns are associated with heritable developmental abnormalities in plants and with cancer in mammals. We have developed a genome-wide DNA methylation ...

PubMed Central

135
The DMM complex prevents spreading of DNA methylation from transposons to nearby genes in Neurospora crassa.
2010-02-05

Transposable elements are common in genomes and must be controlled. Many organisms use DNA methylation to silence such selfish DNA, but the mechanisms that restrict the methylation to appropriate regions are largely unknown. We identified a JmjC domain protein in Neurospora, DNA METHYLATION MODULATOR-1 (DMM-1), that prevents ...

PubMed

136
The DMM complex prevents spreading of DNA methylation from transposons to nearby genes in Neurospora crassa
2010-03-01

Transposable elements are common in genomes and must be controlled. Many organisms use DNA methylation to silence such selfish DNA, but the mechanisms that restrict the methylation to appropriate regions are largely unknown. We identified a JmjC domain protein in Neurospora, DNA METHYLATION MODULATOR-1 (DMM-1), that prevents ...

PubMed Central

137
Loss of galectin-3 expression in mucinous colorectal carcinomas is associated with 5'CpG island methylation in Tunisian patients.
2011-05-01

The ?-galactoside-binding protein galectin-3 (gal-3) has pleitropic biological functions and has been implicated in cell growth, differentiation, adhesion, RNA processing, apoptosis, and malignant transformation. To investigate the pattern of inactivation of the gal-3 gene (LGALS3) in colorectal cancers (CRC), we studied a series of Tunisian patients with CRC to identify ...

PubMed

138
DNA methylation in thyroid tumorigenesis
2011-06-01

Thyroid cancer is the most common endocrine cancer with 1,690 deaths each year. There are four main types of which the papillary and follicular types together account for >90% followed by medullary cancers with 3% to 5% and anaplastic carcinomas making up <3%. Epigenetic events of DNA hypermethylation are emerging as promising molecular targets for cancer detection. Our immediate and long ...

PubMed Central

139
Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients
2010-03-12

BackgroundIn the present study, we determined the gene hypermethylation profiles of normal tissues adjacent to invasive breast carcinomas and investigated whether these are associated with the gene hypermethylation profiles of the corresponding primary breast tumors.MethodsA quantitative methylation-specific PCR assay was used to ...

PubMed Central

140
Promoter methylation status of multiple genes in brain metastases of solid tumors.
2004-01-01

The aberrant methylation of the CpG island promoter regions acquired by tumor cells is one mechanism for loss of gene function. The high methylation rate for RB1 and death-associated protein-kinase gene (DAP-kinase) (60 and 90%, respectively) previously found in brain metastases suggests this ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
141
Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis.
2010-02-18

CpG island hypermethylation is frequently found during gastric carcinogenesis. We investigated methylation profiles of p16, LOX, HAND1, THBD, p41ARC, and APC along multistep gastric carcinogenesis and determined their association with Helicobacter pylori infection. Methylation levels in these six genes were evaluated in noncancerous ...

PubMed

142
Genome-wide screen of promoter methylation identifies novel markers in melanoma
2009-08-01

DNA methylation is an important component of epigenetic modifications, which influences the transcriptional machinery aberrant in many human diseases. In this study we present the first genome-wide integrative analysis of promoter methylation and gene expression for the identification of ...

PubMed Central

143
DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
2004-09-10

The purpose of this research was to examine the DNA methylation profile of meningiomas. Accordingly, we examined the DNA methylation status of ten tumor-related genes (RB1, p16(INK4a), p73, MGMT, ER, DAPK, TIMP-3, p14(ARF), THBS1, and Caspase-8) in 98 meningiomas (68 grade I; 27 grade II; and 3 grade III samples) using ...

PubMed

144
Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer
2010-09-17

BackgroundChanges in DNA methylation of crucial cancer genes including tumor suppressors can occur early in carcinogenesis, being potentially important early indicators of cancer. The objective of this study was to examine a multiplexed approach to assess the methylation of tumor suppressor genes as tumor ...

PubMed Central

145
Prediction of Breast Cancer Risk by Aberrant Methylation in ...
2006-07-01

... Promoter region methylation of Cyclin D2, APC, HIN1, RASSF1A, and RAR 2 was measured in NDL samples by quantitative methylation-specific ...

DTIC Science & Technology

146
DNA methyltransferase inhibition may limit cancer cell growth by disrupting ribosome biogenesis.
2011-02-01

"Mutations" in the pattern of CpG methylation imprinting of the human genome have been correlated with a number of diseases including cancer. In particular, aberrant imprinting of tumor suppressor genes by gain of CpG methylation has been observed in many cancers and thus represents an important alternative pathway ...

PubMed

147
Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer.
2010-11-01

Experiments using cancer cell lines have revealed that CHFR methylation correlates with sensitivity to microtubule inhibitors. However, this marker may not benefit actual clinical cases because it is difficult to detect CHFR methylation without surgically resected samples. Thus, a more easily accessible marker that correlates with sensitivity to ...

PubMed

148
DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia
2010-08-16

BackgroundAberrant promoter DNA methylation has been shown to play a role in acute myeloid leukemia (AML) pathophysiology. However, further studies to discuss the prognostic value and the relationship of the epigenetic signatures with defined genomic rearrangements in acute myeloid leukemia are required.Methodology/Principal FindingsWe carried out ...

PubMed Central

149
DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
2006-01-15

Molecular markers of pancreatic neoplasia could aid in the evaluation of visible pancreatic lesions and indicate neoplasia invisible to imaging. We evaluated methylation-specific PCR (MSP) assays that detect aberrantly methylated DNA for their use as markers of pancreatic neoplasia. Methylation analysis was done on ...

PubMed

150
Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
1998-09-29

The p16INK4a (p16) tumor suppressor gene can be inactivated by promoter region hypermethylation in many tumor types including lung cancer, the leading cause of cancer-related deaths in the U.S. We have determined the timing of this event in an animal model of lung carcinogenesis and in human squamous cell carcinomas (SCCs). In the rat, 94% of ...

PubMed Central

151
Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology
2010-11-23

Background-Sporadic breast cancer like many other cancers is proposed to be a manifestation of abnormal genetic and epigenetic changes. For the past decade our laboratory has identified genes involved in DNA damage response (DDR), apoptosis and immunesurvelliance pathways to influence sporadic breast cancer risk in north Indian population. Further to enhance our knowledge at ...

PubMed Central

152
Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
2008-09-26

Ductal adenocarcinoma of the pancreas is the fourth leading cause of cancer death and is usually diagnosed late. Intraductal papillary mucinous neoplasms are an increasingly recognized precursor to invasive ductal adenocarcinoma of the pancreas. Identifying the alterations in DNA methylation that arise during intraductal papillary mucinous neoplasm development may facilitate ...

PubMed

153
Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas
2008-09-26

Ductal adenocarcinoma of the pancreas is the fourth leading cause of cancer death and is usually diagnosed late. Intraductal papillary mucinous neoplasms are an increasingly recognized precursor to invasive ductal adenocarcinoma of the pancreas. Identifying the alterations in DNA methylation that arise during intraductal papillary mucinous neoplasm development may facilitate ...

PubMed Central

154
Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
2007-06-28

The inactivation of tumor-related genes through the aberrant methylation of promoter CpG islands is thought to contribute to tumor initiation and progression. We therefore investigated promoter methylation events involved in cutaneous melanoma by screening 30 genes of interest for evidence of ...

PubMed

155
Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells.
2003-12-04

DNA methylation plays critical roles in the development and differentiation of mammalian cells, and its dysregulation has been implicated in oncogenesis. This study was designed to determine whether DNA hypomethylation-associated aberrant gene expression is involved in adult T-cell leukemia (ATL) leukemogenesis. We isolated ...

PubMed

156
Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists
2010-07-12

BackgroundDNA methylation and histone acetylation are epigenetic modifications that act as regulators of gene expression. Aberrant epigenetic gene silencing in tumours is a frequent event, yet the factors which dictate which genes are targeted for inactivation are unknown. DNA ...

PubMed Central

157
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
2010-09-03

Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation ...

PubMed Central

158
Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
2008-06-01

Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assure the inheritance of information, which are essential for the proper expression of key regulatory genes in healthy cells, tissues and organs. In the medical field, an increasing body of evidence indicates that altered gene expression or ...

PubMed Central

159
Rapid Assessment of the Heterogeneous Methylation Status of CEBPA in Patients with Acute Myeloid Leukemia by Using High-Resolution Melting Profile.
2011-06-30

Epigenetic inactivation of tumor-suppressor genes, often in association with aberrant DNA methylation of CpG islands in the promoter region of these genes, is a key factor in tumorigenesis. CCAAT/enhancer binding protein alpha (CEBPA) methylation is a favorable prognostic biomarker for acute ...

PubMed

160
Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer
2010-01-05

Background:Testicular germ cell tumour (TGCT) is the most common malignant tumour in young males. Although aberrant DNA methylation is implicated in the pathophysiology of many cancers, only a limited number of genes are known to be epigenetically changed in TGCT. This report documents the genome-wide analysis of differential ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
161
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
2009-12-17

BackgroundCancer cells display widespread changes in DNA methylation that may lead to genetic instability by global hypomethylation and aberrant silencing of tumor suppressor genes by focal hypermethylation. In turn, altered DNA methylation patterns have been used to identify putative tumor suppressor ...

PubMed Central

162
DNA Methylation of Cancer Genome
2009-12-01

DNA methylation plays an important role in regulating normal development and carcinogenesis. Current understanding of the biological roles of DNA methylation is limited to its role in the regulation of gene transcription, genomic imprinting, genomic stability, and X chromosome inactivation. In the past 2 decades, a large number of ...

PubMed Central

163
Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
2011-04-20

BackgroundLung cancer is the leading cause of cancer-related death worldwide. Genetic and epigenetic alterations have been identified frequently in lung cancer, such as promoter methylation, gene mutations and genomic amplification. However, the interaction between genetic and epigenetic events and their significance in lung tumorigenesis remains poorly ...

PubMed Central

164
Metabolic defects provide a spark for the epigenetic switch in cancer
2009-04-10

Cancer is a pathology that is associated with aberrant gene expression and an altered metabolism. While changes in gene expression have historically been attributed to mutations, it has become apparent that epigenetic processes also play a critical role in controlling gene expression during carcinogenesis. Global ...

PubMed Central

165
Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
2009-12-01

Promoter methylation is an important mechanism in gene silencing and is a key epigenetic event in cancer development. Homeobox A5 (HOXA5) is a master regulator of the morphogenesis and cell differentiation to be implicated as a tumor suppressor gene in breast cancer, but its role in lung cancer is still unknown. In this study, we have ...

PubMed

166
Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
2011-06-04

BackgroundLung cancer is a major cause of death worldwide. Gene promoter methylation is a major inactivation mechanism of tumor-related genes, some of which can be served as a biomarker for early diagnosis and prognosis evaluation of lung cancer.MethodsWe determined the promoter methylation of 6 ...

PubMed Central

167
Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation
2010-05-20

BackgroundEpigenetic changes such as aberrant DNA methylation and histone modification have been shown to play an important role in the tumorigenesis of malignant melanoma.ObjectiveTo identify novel tumor-specific differentially methylated regions (DMRs) in human malignant melanoma.MethodsThe aberrant ...

PubMed Central

168
Identification of 5 novel genes methylated in breast and other epithelial cancers
2010-03-05

BackgroundThere are several high throughput approaches to identify methylated genes in cancer. We utilized one such recently developed approach, MIRA (methylated-CpG island recovery assay) combined with CpG island arrays to identify novel genes that are epigenetically inactivated in breast cancer.ResultsUsing this ...

PubMed Central

169
In Vitro Analysis of Integrated Global High-Resolution DNA Methylation Profiling with Genomic Imbalance and Gene Expression in Osteosarcoma
2008-07-30

Genetic and epigenetic changes contribute to deregulation of gene expression and development of human cancer. Changes in DNA methylation are key epigenetic factors regulating gene expression and genomic stability. Recent progress in microarray technologies resulted in developments of high resolution platforms for profiling of genetic, ...

PubMed Central

170
Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
2011-01-28

Hypermethylation at the promoter region is an important epigenetic mechanism underlying the inactivation of tumor suppressor genes and frequently occurs as an early event in the development of different types of cancer including colorectal carcinoma (CRC). The aim of the present study is the detection of methylation status for some tumor suppressor ...

PubMed

171
Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
2011-01-13

The role of epigenetics and significance of aberrant gene regulation in etiology of cancer is a well-established phenomenon. The hallmark of cancer epigenetics is aberrant DNA methylation consisting of global hypomethylation and regional hypermethylation of tumor suppressor genes (TSGs) by DNA ...

PubMed

172
Prediction of Breast Cancer Risk by Aberrant Methylation in ...
2006-07-01

Page 1. AD_____ AWARD NUMBER: DAMD17-01-1-0421 TITLE: Prediction of Breast Cancer Risk by Aberrant ...

DTIC Science & Technology

173
Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy.
2011-07-01

Folic acid (FA) supplementation before and during pregnancy has been associated with decreased risk of neural tube defects although recent reports suggest it may also increase the risk of other chronic diseases. We evaluated exposure to maternal FA supplementation before and during pregnancy in relation to aberrant DNA methylation at two differentially ...

PubMed

174
Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy
2011-07-01

Folic acid (FA) supplementation before and during pregnancy has been associated with decreased risk of neural tube defects although recent reports suggest it may also increase the risk of other chronic diseases. We evaluated exposure to maternal FA supplementation before and during pregnancy in relation to aberrant DNA methylation at two differentially ...

PubMed Central

175
Leukemogenesis: More Than Mutant Genes
2010-01-01

Acute leukemias are characterized by recurring chromosomal aberrations and gene mutations which are critical to disease pathogenesis. It is now evident that epigenetic modifications including DNA methylation and histone modifications contribute significantly to the leukemogenic phenotype. An additional layer of epigenetic complexity is ...

PubMed Central

176
[Bioindication of environmental quality based on plant mutational and modification variability].

The level of mutations (aberrations of chromosomes, gene mutations) and modifications (bilateral asymmetry of the leaves) induced with NG (N-methyl-N-nitro-N-nitro-zoguanidine) and granozane, as well as with environmental pollutants have been studied on Vicia faba, Triticum aestivum, Arabidopsis thaliana, Ligustrum japonicum, Olea ...

PubMed

177
TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.
2011-04-13

Enzymes catalysing the methylation of the 5-position of cytosine (mC) have essential roles in regulating gene expression and maintaining cellular identity. Recently, TET1 was found to hydroxylate the methyl group of mC, converting it to 5-hydroxymethyl cytosine (hmC). Here we show that TET1 binds throughout the genome of embryonic stem ...

PubMed

178
DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.
2009-02-24

Aberrant promoter methylation is recognized as an important feature of breast carcinogenesis. We hypothesized that genetic variation of genes for methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MTR), two critical enzymes in the one-carbon metabolism, may alter DNA methylation levels and thus ...

PubMed

179
Disease-dependent Differently Methylated Regions (D-DMRs) of DNA are Enriched on the X Chromosome in Uterine Leiomyoma.
2011-06-17

Uterine leiomyoma is the most common benign tumor in women. Although responsible gene mutations have not been found in leiomyomas, they represent a progressive disease with irreversible symptoms. To characterize epigenetic features of uterine leiomyomas, the DNA methylation status of a paired sample of leiomyoma and normal myometrium was subjected to a ...

PubMed

180
Inter- and Intra-Individual Variation in Allele-Specific DNA Methylation and Gene Expression in Children Conceived using Assisted Reproductive Technology
2010-07-22

Epidemiological studies have reported a higher incidence of rare disorders involving imprinted genes among children conceived using assisted reproductive technology (ART), suggesting that ART procedures may be disruptive to imprinted gene methylation patterns. We examined intra- and inter-individual variation in DNA ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page
 
181
Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation.
2010-10-27

Chronic inflammation is deeply involved in induction of aberrant DNA methylation, but it is unclear whether any type of persistent inflammation can induce methylation and how induction of cell proliferation is involved. In this study, Mongolian gerbils were treated with five kinds of inflammation inducers [Helicobacter pylori with ...

PubMed

182
Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples.
2010-07-13

Aberrant DNA methylation frequently occurs at gene promoters during cancer progression. It is important to identify these loci because they are often misregulated and drive tumorigenesis. Bisulfite sequencing is the most direct and highest resolution assay for identifying aberrant promoter ...

PubMed

183
Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples
2010-09-01

Aberrant DNA methylation frequently occurs at gene promoters during cancer progression. It is important to identify these loci because they are often misregulated and drive tumorigenesis. Bisulfite sequencing is the most direct and highest resolution assay for identifying aberrant promoter ...

PubMed Central

184
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
2010-11-15

Silencing of tumor suppressor genes plays a vital role in head and neck carcinogenesis. In this study, we aimed to evaluate to the utility of aberrant promoter hypermethylation for detection in a panel of 10 genes (KIF1A, EDNRB, CDH4, TERT, CD44, NISCH, PAK3, VGF, MAL and FKBP4) in head and neck squamous cell carcinoma (HNSCC) via a ...

PubMed

185
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses
2010-11-15

Silencing of tumor suppressor genes plays a vital role in head and neck carcinogenesis. In this study, we aimed to evaluate to the utility of aberrant promoter hypermethylation for detection in a panel of 10 genes (KIF1A, EDNRB, CDH4, TERT, CD44, NISCH, PAK3, VGF, MAL and FKBP4) in head and neck squamous cell carcinoma (HNSCC) via a ...

PubMed Central

186
Comprehensive profiling of zebrafish hepatic proximal promoter CpG island methylation and its modification during chemical carcinogenesis
2011-01-04

BackgroundDNA methylation is an epigenetic mechanism associated with regulation of gene expression and it is modulated during chemical carcinogenesis. The zebrafish is increasingly employed as a human disease model; however there is a lack of information on DNA methylation in zebrafish and during fish tumorigenesis.ResultsA novel CpG ...

PubMed Central

187
Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
2010-03-21

Histone deacetylase (HDAC) inhibitors have shown significant activity in the treatment of cutaneous T-cell lymphomas (CTCL). The epigenetic alterations of CTCL not only are limited to altered histone acetylation but also include aberrant DNA gene methylation hence, the combination of an HDAC inhibitor with a DNA demethylating agent is ...

PubMed Central

188
Isolated imprinting mutation of the DLK1/GTL2 locus associated with a clinical presentation of maternal uniparental disomy of chromosome 14
2009-07-01

The clinical phenotypes of maternal and paternal uniparental disomy of chromosome 14 (UPD14) are attributed to dysregulation of imprinted genes. A large candidate locus exists within 14q32, under the regulation of a paternally methylated intergenic differentially methylated region (IG-DMR). We present a patient with clinical features ...

PubMed Central

189
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.
2011-01-01

Aberrant DNA methylation plays a pivotal role in carcinogenesis and its mapping is likely to provide biomarkers for improved diagnostic and risk assessment in prostate cancer (PCa). We quantified and compared absolute methylation levels among 28 candidate genes in 48 PCa and 29 benign prostate hyperplasia (BPH) ...

PubMed

190
Methylation of the E-cadherin Gene in Bladder Neoplasia and in Normal Urothelial Epithelium from Elderly Individuals
2001-09-01

Decreased expression of the epithelial cell adhesion protein E-Cadherin occurs in several forms of human epithelial-derived cancers, including bladder cancers. We investigated the possibility that aberrant methylation of the CpG island flanking the 5? transcriptional start site of the e-cadherin gene is responsible for the decreased ...

PubMed Central

191
Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination
2010-09-07

BackgroundAbnormal DNA methylation is well established for breast cancer and contributes to its progression by silencing tumor suppressor genes. DNA methylation profiling platforms might provide an alternative approach to expression microarrays for accurate breast tumor subtyping. We sought to determine whether the distinction of the ...

PubMed Central

192
Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
2010-11-23

The aberrant changes of tumor suppressor genes (TSGs) are now recognized as an important mechanism contributing to the development of acute myeloid leukemia (AML). CCAAT/enhancer binding protein zeta (C/EBP?), a candidate TSG, has been found to be involved in cancers including AML. We detected the methylation status of C/EBP? promoter ...

PubMed

193
An Integrative Genomic and Epigenomic Approach for the Study of Transcriptional Regulation
2008-03-26

The molecular heterogeneity of acute leukemias and other tumors constitutes a major obstacle towards understanding disease pathogenesis and developing new targeted-therapies. Aberrant gene regulation is a hallmark of cancer and plays a central role in determining tumor phenotype. We predicted that integration of different genome-wide epigenetic regulatory ...

PubMed Central

194
Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.
2006-11-01

Aberrant hypermethylation of the CpG islands in the promoter region plays a casual role in the inactivation of various key genes involved in the cell cycle regulatory cascade, which could result in loss of cell cycle control. The aim of the present study was to investigate the role of promoter methylation of genes ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 8 9 10 Next Page Last Page